Literature DB >> 21713659

Mast cell proteases as protective and inflammatory mediators.

George H Caughey1.   

Abstract

Proteases are the most abundant class of proteins produced by mast cells. Many of these are stored in membrane-enclosed intracellular granules until liberated by degranulating stimuli, which include cross-linking of high affinity IgE receptor F(c)εRI by IgE bound to multivalent allergen. Understanding and separating the functions of the proteases is important because expression differs among mast cells in different tissue locations. Differences between laboratory animals and humans in protease expression also influence the degree of confidence with which results obtained in animal models of mast cell function can be extrapolated to humans. The inflammatory potential of mast cell proteases was the first aspect of their biology to be explored and has received the most attention, in part because some of them, notably tryptases and chymases, are biomarkers of local and systemic mast cell degranulation and anaphylaxis. Although some of the proteases indeed augment allergic inflammation and are potential targets for inhibition to treat asthma and related allergic disorders, they are protective and even anti-inflammatory in some settings. For example, mast cell tryptases may protect from serious bacterial lung infections and may limit the "rubor" component of inflammation caused by vasodilating neuropeptides in the skin. Chymases help to maintain intestinal barrier function and to expel parasitic worms and may support blood pressure during anaphylaxis by generating angiotensin II. In other life-or-death examples, carboxypeptidase A3 and other mast cell peptidases limit systemic toxicity of endogenous peptideslike endothelin and neurotensin during septic peritonitis and inactivate venom-associated peptides. On the other hand, mast cell peptidase-mediated destruction of protective cytokines, like IL-6, can enhance mortality from sepsis. Peptidases released from mast cells also influence nonmast cell proteases, such as by activating matrix metalloproteinase cascades, which are important in responses to infection and resolution of tissue injury. Overall, mast cell proteases have a variety of roles, inflammatory and anti-inflammatory, protective and deleterious, in keeping with the increasingly well-appreciated contributions of mast cells in allergy, tissue homeostasis and innate immunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713659      PMCID: PMC3954859          DOI: 10.1007/978-1-4419-9533-9_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  174 in total

1.  Inhibition of chymase reduces vascular proliferation in dog grafted veins.

Authors:  S Takai; A Yuda; D Jin; M Nishimoto; M Sakagichi; S Sasaki; M Miyazaki
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

2.  Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses.

Authors:  E M Erin; B R Leaker; A Zacharasiewicz; L A Higgins; G C Nicholson; M J Boyce; P de Boer; R C Jones; S R Durham; P J Barnes; T T Hansel
Journal:  Clin Exp Allergy       Date:  2006-04       Impact factor: 5.018

3.  Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways.

Authors:  P J Wolters; M Laig-Webster; G H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2000-02       Impact factor: 6.914

4.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

Review 5.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

6.  Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I.

Authors:  P J Wolters; W W Raymond; J L Blount; G H Caughey
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

7.  Mast cell cathepsins C and S control levels of carboxypeptidase A and the chymase, mouse mast cell protease 5.

Authors:  Frida Henningsson; Paul Wolters; Harold A Chapman; George H Caughey; Gunnar Pejler
Journal:  Biol Chem       Date:  2003 Oct-Nov       Impact factor: 3.915

8.  Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase.

Authors:  B T Frank; J C Rossall; G H Caughey; K C Fang
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

9.  Angiotensin I conversion by human and rat chymotryptic proteinases.

Authors:  B U Wintroub; N B Schechter; G S Lazarus; C E Kaempfer; L B Schwartz
Journal:  J Invest Dermatol       Date:  1984-11       Impact factor: 8.551

10.  Modulation of thrombin and thrombin receptor peptide mitogenicity by human lung mast cell tryptase.

Authors:  T Hartmann; S J Ruoss; G H Caughey
Journal:  Am J Physiol       Date:  1994-08
View more
  60 in total

Review 1.  Mediators released during human anaphylaxis.

Authors:  Shelley F Stone; Simon G A Brown
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

3.  Anti-Eimeria activity of berberine and identification of associated gene expression changes in the mouse jejunum infected with Eimeria papillata.

Authors:  Mohamed A Dkhil; Mahmoud S Metwaly; Saleh Al-Quraishy; Nour E Sherif; Denis Delic; Suliman Y Al Omar; Frank Wunderlich
Journal:  Parasitol Res       Date:  2015-02-10       Impact factor: 2.289

4.  Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.

Authors:  Jessica A Chadwick; J Spencer Hauck; Jeovanna Lowe; Jeremiah J Shaw; Denis C Guttridge; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  FASEB J       Date:  2015-07-15       Impact factor: 5.191

5.  IL-33/ST2 axis promotes mast cell survival via BCLXL.

Authors:  Jun-Xia Wang; Shinjiro Kaieda; Sarah Ameri; Nadia Fishgal; Daniel Dwyer; Anthony Dellinger; Christopher L Kepley; Michael F Gurish; Peter A Nigrovic
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

Review 6.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

7.  Investigating mast cell secretory granules; from biosynthesis to exocytosis.

Authors:  Nurit P Azouz; Mitsunori Fukuda; Marc E Rothenberg; Ronit Sagi-Eisenberg
Journal:  J Vis Exp       Date:  2015-01-26       Impact factor: 1.355

Review 8.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

9.  Globule Leukocytes and Other Mast Cells in the Mouse Intestine.

Authors:  Peter Vogel; Laura Janke; David M Gravano; Meifen Lu; Deepali V Sawant; Dorothy Bush; E Shuyu; Dario A A Vignali; Asha Pillai; Jerold E Rehg
Journal:  Vet Pathol       Date:  2017-05-11       Impact factor: 2.221

10.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.